BriaCell Therapeutics Corp. Warrant

$1.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.28 (-20.21%) Today
$0.00 (0.00%) As of 8:05 PM UTC after-hours

Why Robinhood?

You can watch BCTXW and buy or sell other stocks, options, and ETFs commission-free!

About BCTXW

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.

CEO
William V. Williams, MD
Employees
—
Headquarters
West Vancouver, British Columbia
Founded
2006
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
93.08K
High Today
$1.35
Low Today
$1.06
Open Price
$1.35
Volume
53.71K
52 Week High
$1.99
52 Week Low
$0.64

You May Also Like

KAI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure